A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Platform Clinical Study for Conquering Scleroderma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth
- Status
- COMPLETED
- Phase
- PHASE1
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
- Status
- RECRUITING
- Phase
- N/A
A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry
- Status
- RECRUITING
- Phase
- N/A
Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Screening Adults With Obesity to Reduce Heart Failure Events
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA